• SENSEX 78,890.97
    1,589.57 (+2.06%)
  • BANKNIFTY 55,913.60
    373.55 (+0.67%)
  • NSE
    1,850.00 1,878.00(%)
  • ITC
    277.30 252.80(%)
  • Tube Investments
    2,227.65 2,006.00(%)
  • Axis Bank
    1,274.70 1,418.30(%)
  • Reliance Industries
    1,303.90 1,152.30(%)
  • HDFC Life Insur.
    546.00 788.50(%)
  • Aurobindo Pharma
    1,748.85 1,739.95(%)
  • Lenskart Solut.
    767.40 725.00(%)
  • HDFC Bank
    762.80 1,017.90(%)
  • Titan Company
    4,858.90 5,187.45(%)
  • Petronet LNG
    320.00 326.40(%)
  • CG Power & Ind
    812.40 525.50(%)
  • Jio Platforms
    1,442.00 1,490.00(%)
  • Tonbo Imaging
    1,460.00 1,343.80(%)
  • Multi Comm. Exc.
    3,395.00 3,537.00(%)
  • Larsen & Toubro
    4,071.00 4,440.00(%)
  • Saregama India
    613.80 305.65(%)
  • Bajaj Finance
    1,054.00 1,177.60(%)
  • Cummins India
    4,036.95 3,883.30(%)
  • Bajaj Auto
    10,750.10 12,470.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Marksans Pharma Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 3285.0
  • ISIN : INE750C01026
301.65 -14 (-4.33%)
  • As on 05 Nov 2026 (EOD)

  • Today’s Low

    296.60

  • Today’s High

    327.00

  • Open

    316.90

  • Perv Close

    315.30

  • 52W Low

    155.00

  • 52W High

    350.95

Key Indicators

  • P/E(TTM)

    42.42

  • Mar.Cap (₹Cr.)

    13,669.68

  • Div & Yield %

    0.30

  • Book Value(₹)

    36.46

  • Debt-Equity Ratio

    -4.33

  • AGM Date

    04-Nov-2026

  • EPS

    7.10

  • P/E Ratio

    42.42

Financials Ratios

  • Debt-Equity Ratio

    0.10

  • Mar.Cap (₹Cr.)

    13,669.68

  • RONW (%)

    16.53

  • ROCE (%)

    20.78

Score Board

  • Equity (₹ in Cr.)

    45.32

  • BV (₹)

    36.50

  • Sales( ₹ in Cr.)

    1,341.48

  • NP (in Cr.)

    299.80

  • NP Var(%)

    60.0

  • Div%

    90.0

  • CPS (₹)

    7.40

  • EPS (₹)

    6.60

  • Traded Value (₹ in Lakhs)

    13,647.03

  • 52 Week High

    350.95

  • 52 Week Low

    155.00

  • Price BSE

    301.0

  • Price NSE

    302.00

  • Market Capital( in Cr.)

    13,647.03

  • P/C Ratio

    40.80

  • P/E Ratio

    45.50

  • Price Vs.BV

    6.60

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 1,341.48 1,174.37 853.27 655.20 658.29 599.55
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 1,341.48 1,174.37 853.27 655.20 658.29 599.55
Other Income 103.53 65.79 62.07 60.48 42.25 31.16
Stock Adjustments -3.30 -0.70 7.25 10.19 -3.89 -0.55
Total Income 1,441.71 1,239.46 922.59 725.87 696.65 630.16
EXPENDITURE :            
Raw Materials 675.49 639.24 486.18 404.64 373.70 337.36
Power and Fuel Cost 32.95 30.73 26.04 14.24 11.49 10.90
Employee Cost 121.98 101.68 77.19 56.09 60.46 54.64
Other Manufacturing Expenses 65.94 64.62 46.10 21.09 5.25 6.98
Selling and Administration Expenses 96.71 112.99 73.19 61.54 67.57 60.08
Miscellaneous Expenses 21.55 16.32 11.88 15.89 22.22 15.31
Employee Benefit Expenses 121.98 101.68 77.19 56.09 60.46 54.64
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,014.62 965.58 720.58 573.49 540.68 485.28
Operating Profit 427.10 273.88 202.01 152.38 155.97 144.87
Interest 1.33 1.17 0.99 3.61 3.80 5.35
Gross Profit 425.77 272.71 201.02 148.77 152.17 139.52
Depreciation 34.23 29.45 29.13 16.74 17.66 15.19
Profit Before Tax 391.54 243.26 171.89 132.03 134.51 124.33
Current Tax 86.29 52.14 37.46 29.34 30.02 28.19
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 4.55 2.84 0.68 -0.17 0.50 -2.24
Reported Net Profit 300.70 188.27 133.76 102.87 103.99 98.38
Extraordinary Items 0.90 0.51 0.07 -0.05 0.00 0.03
Adjusted Net Profit 299.80 187.76 133.69 102.92 103.99 98.35
Adjustment below Net Profit 1.04 -0.30 0.28 -8.64 0.05 -0.20
P & L Balance brought forward 505.78 345.00 233.61 155.21 61.41 -32.69
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 36.25 27.19 22.66 15.82 10.23 4.09
P & L Balance carried down 771.26 505.78 345.00 233.61 155.21 61.41
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 90.00 80.00 60.00 50.00 25.00 25.00
Dividend Per Share(Rs) 0.90 0.80 0.60 0.50 0.25 0.25
Earnings Per Share-Unit Curr 6.64 4.15 2.95 2.27 2.54 2.40
Earnings Per Share(Adj)-Unit Curr 6.64 4.15 2.95 2.27 2.54 2.40
Book Value 36.46 30.53 26.98 24.52 16.90 14.65
Book Value(Adj)-Unit Curr 36.46 30.53 26.98 24.52 16.90 14.65

Shareholding Pattern

  • Promoter Group

    43.87%

  • Public Share Holding

    56.13%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 198,822,009 43.87 198,822,009 5
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 198,822,009 43.87 198,822,009 5
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 39,050,881 8.62 39,050,881 1
Financial Institutions / Banks 2,911 0.00 911 3
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 47,308,300 10.44 47,308,300 170
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 16,869,645 3.72 16,869,645 12
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 8,228,680 1.82 8,228,680 23
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 111,460,417 24.60 111,458,417 209
2] Non Institution
Bodies Corporate 8,387,264 1.85 8,386,264 1,077
Clearing Members 167,656 0.04 167,656 39
Directors of their Relatives 0 0.00 0 0
Employees 2,365 0.00 2,365 8
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 6,771,406 1.49 6,771,406 5,003
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 3,590,962 0.79 3,590,962 2,953
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 16,432,382 3.63 16,432,382 24
Individuals holding nominal share capital up to Rs. 1 lakh 106,143,992 23.42 105,933,182 238,151
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 456,244 0.10 456,244 10
Others 850,434 0.19 850,434 1
Sub Total 142,881,320 31.53 142,669,510 247,294
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 453,163,746 100.00 452,949,936 247,508

Company Background

Marksans Pharma LtdPharmaceuticals - Indian - Formulations

  • Marksans Pharma Ltd
  • BSE Code : 3285.0
  • ISIN : INE750C01026

  • Incorporation Year

    1992

  • Registered Office

    11th Flr GRANDEUR Oshiwara
    Veera Desai Extn Rd Andheri(W), Mumbai,
    Maharashtra-400053

  • Telephone

    91-22-40012000

  • FAX

    91-22-40012011

  • Chairman

    Mark Saldanha

  • Managing Director

    Mark Saldanha

  • Company Secretary

    HARSHAVARDHAN PANIGRAHI

  • Auditor

    MSKA & Associates LLP

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    Bigshare Services Pvt Ltd
    Office No S6-2,
    Pinnacle Busine.Park,Mahakali Caves Road
    Mumbai - Mumbai - 400093

Marksans Pharma Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Marksans Pharma 301.15 1,445.01 1,341.48 42.42 25.59
Abbott India 27,146.85 7,217.19 6,929.05 35.73 43.78
Astrazeneca Phar 6,365.10 2,304.07 2,275.58 93.81 27.86
Glaxosmi. Pharma 2,532.60 3,932.76 3,790.20 40.46 58.17
Evonile Pharma 1,736.60 393.10 354.33 43.85 15.94
Cipla 1,400.10 20,102.60 18,979.95 42.67 13.88
Bliss GVS Pharma 625.60 773.53 729.81 40.78 12.51
Amrutanjan Healt 511.45 520.13 502.55 27.39 24.16
Fermenta Biotec. 439.00 474.15 450.25 20.49 18.77
Guj. Themis Bio. 387.70 168.25 165.82 103.66 18.05
Ambalal Sarabhai 35.67 19.52 3.94 66.06 6.77